Science · Open for opinions
Will a clinical trial of psilocybin for neuropathy in humans be registered on ClinicalTrials.gov by 10/31/2026?
Consider records in the clinical database between 09/07/2026 and 10/31/2026 after promising preclinical results published in Nature. 15 opinions, 73% No
- Yes — 27%
- No — 73%
Deadline: October 31, 2026 at 11:59 PM UTC · 15 opinions
Resolution rules
Consider records in the clinical database between 09/07/2026 and 10/31/2026 after promising preclinical results published in Nature.
Source: www.nature.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 07/09/2026 (00:00, horário de Brasília) até 31/10/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se um novo estudo clínico de Fase 1 ou 2 testando psilocibina para neuropatia periférica induzida por quimioterapia for oficialmente registrado na base pública ClinicalTrials.gov até 31/10/2026. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 73% of the votes: an opinion on it that turns out right earns about 27 points, a wrong one costs about 73.